FEMFAV-XT
The FEMFAV-XT is a multipurpose haematinic supplement tablet which comprises Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg and Zinc 22.5 mg. The drug has been offered by Bioglint Derma Care Ltd. The combination of these three nutrients helps in fulfilling the nutritional requirements, such as iron, folic acid and zinc, that are required by women who are in their reproductive age and even pregnant women. Also, people who have issues with skin and hair need to take all these nutrients together. Ferrous Ascorbate is a form of chelated iron which contains Vitamin C (Ascorbic Acid) in itself and provides better bioavailability as well as lesser gastric symptoms than ordinary iron compounds.
The FEMFAV-XT comes in a 10 x 10 Alu-Alu blister pack for effective protection of the product and is distributed through Bioglint Derma Care Ltd’s Derma PCD Franchise.
FEMFAV-XT Tablets are prescribed by dermatologists, gynaecologists, and general physicians for the management of:
The combination of FEMFAV-XT offers nutrition through three important micronutrients. The compound Ferrous Ascorbate contains iron in the chelated state protected by Ascorbic Acid (vitamin C). It guarantees the most effective assimilation in the small intestine with less gastric irritation than ferrous sulfate. Iron is necessary for the formation of haemoglobin and myoglobin, the process of oxygen transportation and energy production. Folic acid (vitamin B9) turns into tetrahydrofolate – a coenzyme which participates in the processes of DNA creation, cell proliferation, red blood cell production and embryo neural tube formation. Zinc is an essential trace element that takes part in more than 300 enzymatic reactions and is responsible for such functions as the immune system, wound healing, collagen synthesis, protein metabolism and skin cell restoration.
FEMFAV-XT Tablets are intended for oral use only and should be taken once daily after food, or as directed by a registered medical practitioner. Taking the tablet after meals helps minimise gastric discomfort. Do not crush or chew the tablet. Avoid taking with antacids, milk, tea, or coffee within 1–2 hours of administration as these may impair iron absorption. Duration of therapy should be as advised by the physician.
FEMFAV-XT is generally well tolerated due to the use of Ferrous Ascorbate (a more gastric-friendly form of iron). Some patients may experience mild, transient effects including:
Patients experiencing persistent or severe side effects should discontinue use and consult their physician or dermatologist promptly.
FEMFAV-XT is contraindicated in patients with haemochromatosis, haemolytic anaemia, or iron-overload conditions. It should not be used in patients with known hypersensitivity to any component of the formulation. Use with caution in patients with peptic ulcer disease or inflammatory bowel disease.
Store FEMFAV-XT Tablets in a cool and dry place below 25°C, protected from direct sunlight and moisture. The Alu-Alu blister packaging provides excellent protection — keep tablets in original packaging until use. Store out of reach of children.
| Composition | Ferrous Ascorbate 100mg + Folic Acid 1.5mg + Zinc 22.5mg |
| Dosage Form | Oral Tablet |
| Packing | 10 × 10 Alu-Alu Blister |
| Company | Bioglint Derma Care |
| Category | Haematinic / Nutritional / Derma Tablet |
Bioglint Derma Care invites pharma professionals, distributors, and derma-focused medical representatives across India to partner for the Derma PCD Franchise of FEMFAV-XT and the complete Bioglint nutritional and haematinic tablet range. Iron-folic acid-zinc combinations are among the most prescribed nutritional tablets across gynaecology, dermatology, and general medicine, ensuring consistently high demand and strong business potential for franchise partners.
For Derma PCD Franchise enquiries for FEMFAV-XT and the complete Bioglint Derma Care product range, contact us today and join one of Haryana’s most trusted derma franchise companies.
Disclaimer: FEMFAV-XT is a medicinal/dermatological product. Use strictly under the supervision of a registered medical practitioner or dermatologist. This document is for informational and franchise marketing purposes only and does not constitute medical advice.